Testing effectiveness (Phase 2)Looking for participantsNCT07289763
What this trial is testing
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
Who this might be right for
Primary Membranous Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 75